LYCOS RETRIEVER 
Serzone: Liver Failures
built 279 days ago
"There is no evidence Serzone is any better than any of half a dozen or more other antidepressants with less risk," Wolfe says. "The FDA is making a reckless statement by saying something with no unique benefit -- but with a unique risk -- should stay on the market. They are giving the impression it is OK, and that will lead to more cases of liver failure and death."
Source:
Serzone is an anti-depressant. It is often used to treat a specific form of depression. Unfortunately Serzone has been linked to liver failure. According to the manufacturer the rate of liver failure associated with Serzone use is about 3-4 times than greater than non-users.
Source:
Serzone carries a unique risk of liver failure that is not seen with the other antidepressants. The FDA and the drug's manufacturer are encouraging doctors to carefully weigh risks and benefits in prescribing Serzone when deciding among alternative treatments available for depression.
Source:
Serzone should be discontinued if clinical signs or symptoms suggest liver failure. If any of these signs exist, you should report them immediately to an experienced attorney, who can possibly assist you with a case.
Source:
The FDA and BMS added a black box warning and strengthened the warnings, contraindications, and precautions sections of the Serzone antidepressant label. Serzone liver failure leading to transplant and/or death has continued to be reported
Source:
In January 2002, a "black box" warning was added to Serzone packing inserts to warn of life-threatening liver damage. Despite the strongest issued FDA drug warning, Serzone side effects failed to decrease, which is typically seen among older medications. When Public Citizen first sought a Serzone ban in March 2003, the group cited 21 cases of liver failure and 11 deaths between when Serzone was first marketed in 1994 and the spring of 2002.
Source:
MORE ABOUT
Liver Failures